Changes in thymus- and activation-regulated chemokine (TARC) associated with allergen immunotherapy in patients with perennial allergic rhinitis

Journal of Investigational Allergology and Clinical Immunology

Volumn 15, Issue 3, 2005, Pages 172-176

  Takeuchi, Hiromi ^a   Yamamoto, Y ^a   Kitano, H ^a   Enomoto, T ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Allergic rhinitis; House dust mite; Immunotherapy; Thymus and activation regulated chimokine (TARC)

Indexed keywords

ALLERGEN; CHEMOKINE RECEPTOR CCR4; HOUSE DUST ALLERGEN; LIGAND; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; IMMUNOTHERAPY; INFLAMMATION; LYMPHOCYTE MIGRATION; MALE; NOSE OBSTRUCTION; PATHOGENESIS; PERENNIAL RHINITIS; RHINORRHEA; SNEEZING; SYMPTOMATOLOGY; TH2 CELL;

ADOLESCENT; ADULT; ALLERGENS; ANTIGENS, DERMATOPHAGOIDES; CHEMOKINES, CC; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 27544503211     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Luster AD. Antichemokine immunotherapy for allergic diseases. Curr Opin Allergy Clin Immunol 2001;1:561-567.
2. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Immunology 2001;1:108-116.
3. Keskin G, Inal A, Ali Sari R, Sengül A, Sahin M, Turgay M, and Kinikli G. Serum IFN-γ and IL-10 levels before and after specific immunotherapy in patients with allergic rhinitis. Allergol et Immunopathol 1999;27:261-264.
4. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, and Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997;272:15036-42.
5. Kawasaki S, Takizawa H, Yoneyama H, Nkayama T, Fujisawa R, Izumizaki M, Imai T, Yoshie O, Homma I, Yamamoto K, and Matsushima K. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. Immunol 2001;107:2055-2062.
6. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, asahina A, Onai N, Matsushima K, and Tamaki K. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-541.
7. Panina-Bordignon P, Papi A, Mariani M, Lucia PD, Casoni G, Bellettato C, Buonsanti C, Miotto D, Mapp C, Villa A, Arrigoni G, Fabbri LM, and Sinigaglia F. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. Clinical Invest 2001;107:1357-1364.
8. Terada N, Nomura T, Kim WJ, Otsuka Y, Takahashi R, Kishi H, Yamashita T, Sugawara N, Fukuda S, Ikedaito T and Konnno Y. Expression of C-C chemokine TARC in human nasal mucosa and its regulation by cytokines. Clinical and Exp Allergy 2001;31:1923-1931.
9. Sandoval-Lopez G, Teran LM TARC: novel mediator of allergic inflammation. Clin Exp allergy 2001;31:1809-1812.
10. Leung T, Wong C, Chan IHS, Ip W, Lam KWK, and Wong GWK. Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. J Allergy Clin Immunol 2002;110:404-409.
11. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, Gray PW, Chantry D, Suzuki R and Yoshie O. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002;110:139-146.
12. Hijnen D, Bruin-Weller M, Oosting B, Lebre c, Jong E, Bruijnzeel-Koomen C, and Knol E. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) level in allergic diseases. TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol. 2004;113:334-340.
13. MacGlashan D Jr. Inflammatory mechanisms in allergic disease. Clin Allergy Immunol 2002;16:519-532.
14. Goebeler M, Trautmann A, Voss A, Bröcker E, Toksoy A, and Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation allergic contact hypersensitivity. Am J Pathol 2001;158:431-440.
15. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, Mizutani H, and Matsushima K. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. Clin Invest 1999;104:1097-1105.
16. Kaplan AP. Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol 2001;124:423-431.
17. + lymphocytes into lesional atopic dermatitis skin. Invest Dermatol 2000;115:640-646.
18. Abi-Younes S, Si-Tahar M, Luster AD. The CC chemokines MDC and TARC induce platelet activation via CCR4. Thromb Res 2002;101:279-289.